PTI Launches Game-Based Learning for the Pharma, Biotech and Medical Device Industries
Pharmaceutical Training International (PTI), the leading supplier of online and public, event-based training courses for the pharma, biotech and medical device sectors, has launched a range of game-based e-learning courses. PTI’s unique game-based modules offer new interactive approaches using both 2D and 3D interactive environments. Users will benefit from a more engaging, entertaining and cost-saving method of acquiring new skills through role-play in real world scenarios. To mark the launch, PTI is running a competition until the 26 March which provides access to the new platform and a chance to win a free e-learning course or a 50% discount on a PTI public, event-based training course.
PTI is the first company to bring the innovative game-based interactive approach to training in the (bio)pharma and medical device sectors, enhancing its existing range of popular e-Learning courses. Including topics in business strategy, clinical, manufacturing, medical devices and diagnostics, R&D and regulatory affairs, a range of modules have now been created to allow ‘players’ to learn through interactive quizzes and a 3D virtual environment. Already used successfully in other sectors, the game-based learning approach enhances traditional training methods for personnel in the (bio)pharma and medical device industries, promoting friendly competition and providing motivation for staff to become more efficient, productive and knowledgeable.
Speaking about this new approach, PTI’s Managing Director, Rosie Bernard said: “At PTI, we want to bring the very best learning experience to our customers, whether they are looking for distance learning, event based or tailored on-site training. Game-based learning is a new approach for our customers that will help them develop new skills in a much more engaging and entertaining way.”
Competition entrants can experience and explore the 3D interactive environment while competing with colleagues around the globe by selecting their area of interest and completing an interactive quiz. The competition closes on Thursday 26 March and winners will be selected on Friday 27 March 2015.
For UK start-ups and SMEs, PTI is able to offer a special discount on training courses on an ongoing basis as a Cogent-accredited training partner for the Science Industry Partnership (SIP) skills for growth programme.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.